This chapter is focused on the origins of biolaw, placing its birth on theoretical and procedural developments of American bioethics, and showing how this field influenced European Law's regulation, jurisprudence and instruments. Historical events that triggered the emergence of American bioethics are analysed, as well as two paradigmatic international texts identifying principles to govern biomedical research with human subjects (Nuremberg Code and Belmont Report). The impact of the seminal book Principles of Biomedical Ethics and its influence on the emergence of what was later known as "European bioethics and biolaw" are also thoroughly explored. Finally, the chapter addresses the birth of European biolaw, which was originally aimed at defining and providing content to ethical principles related to autonomy, dignity, integrity and vulnerability, understood as four important bases for European bioethics and biolaw. Those basic ethical principles could not be understood as universal ideas or eternal truths, but rather, they had the status of "deliberative guidelines" and fundamental values of European culture.
InceptionThe birth of biolaw is not related to a single event, but, rather, it is a multifactorial phenomenon. Certainly, much of its first epistemology was developed in Europe where biolaw gradually acquired a certain procedural consistency and got an incipient disciplinary status. However, and although it is a statement that can be discussed, its conceptual roots, while have some backgrounds in Europe, essentially grew crossing the Atlantic Ocean, namely, in the United States of America. The story is well known, but it has never been linked before to biolaw. It is time to do it.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.